Evolus, Inc. (EOLS)
7.14
-0.55
(-7.15%)
USD |
NASDAQ |
Oct 02, 16:00
7.135
0.00 (0.00%)
After-Hours: 20:00
Evolus Profit Margin (Quarterly) : -9.58% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.58% |
| March 31, 2026 | -14.59% |
| December 31, 2025 | 0.14% |
| September 30, 2025 | -22.82% |
| June 30, 2025 | -24.70% |
| March 31, 2025 | -27.57% |
| December 31, 2024 | -8.60% |
| September 30, 2024 | -31.38% |
| June 30, 2024 | -16.96% |
| March 31, 2024 | -22.09% |
| December 31, 2023 | -19.40% |
| September 30, 2023 | -33.83% |
| June 30, 2023 | -36.76% |
| March 31, 2023 | -35.45% |
| December 31, 2022 | -30.16% |
| Date | Value |
|---|---|
| September 30, 2022 | -59.81% |
| June 30, 2022 | -63.16% |
| March 31, 2022 | -51.61% |
| December 31, 2021 | -52.45% |
| September 30, 2021 | -72.85% |
| June 30, 2021 | -59.78% |
| March 31, 2021 | 52.29% |
| December 31, 2020 | -538.0% |
| September 30, 2020 | -64.88% |
| June 30, 2020 | -270.6% |
| March 31, 2020 | -188.0% |
| December 31, 2019 | -74.60% |
| September 30, 2019 | -204.9% |
| June 30, 2019 | -1.63K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -15.03% |
| Return on Invested Capital | -25.84% |
| Gross Profit Margin (Quarterly) | 66.18% |
| Operating Margin (Quarterly) | -3.92% |
| Return on Net Operating Assets | -19.73% |